Neuroendocrine Tumor Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 17
SKU : PH2122
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
How big is the Neuroendocrine Tumor Treatment Market ?
Global Neuroendocrine Tumor Treatment Market reached USD 5,053.2 million in 2022 and is projected to witness lucrative growth by reaching up to USD 10,398.7 million by 2031.
Who are the Key players contributing to the market's growth?
The major global players in the market include Pfizer, Inc., Ipsen Pharmaceuticals, Novartis, AVEO Pharmaceuticals, Inc., Eli Lilly & Company, CK Hutchison Holdings (HUTCHMED), C.H. Boehringer Sohn Ag & Co. KG (Boehringer Ingelheim International GmbH), Lantheus Holdings Inc, Merck & Co Inc and Sanofi.
Related Reports
pharmaceuticalsTriple Negative Breast Cancer Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 22
Starting from
$4350
pharmaceuticalsSalivary Gland Cancer Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 04
Starting from
$4350
pharmaceuticalsEurope Liver Cancer Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 March 05
Starting from
$3750
pharmaceuticalsMalignant Mesothelioma Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 June 07
Starting from
$4350
pharmaceuticalsLung Cancer Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 27
Starting from
$4350
pharmaceuticalsUrinary Tract Cancer Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 06
Starting from
$4350